Your browser doesn't support javascript.
loading
Molecular associations of response to the new-generation BTK inhibitor zanubrutinib in marginal zone lymphoma.
Tatarczuch, Maciej; Waltham, Mark; Shortt, Jake; Polekhina, Galina; Hawkes, Eliza A; Ho, Shir-Jing; Trotman, Judith; Brasacchio, Daniella; Co, Melannie; Li, Jessica; Ramakrishnan, Vanitha; Dunne, Karin; Opat, Stephen S; Gregory, Gareth P.
Afiliación
  • Tatarczuch M; Monash Hematology, Monash Health, Melbourne, VIC, Australia.
  • Waltham M; Blood Cancer Therapeutics Laboratory, Department of Medicine, School of Clinical Sciences at Monash Health, Faculty of Medicine, Nursing & Health Sciences, Monash University, VIC, Australia.
  • Shortt J; Monash Hematology, Monash Health, Melbourne, VIC, Australia.
  • Polekhina G; Blood Cancer Therapeutics Laboratory, Department of Medicine, School of Clinical Sciences at Monash Health, Faculty of Medicine, Nursing & Health Sciences, Monash University, VIC, Australia.
  • Hawkes EA; Monash Hematology, Monash Health, Melbourne, VIC, Australia.
  • Ho SJ; Blood Cancer Therapeutics Laboratory, Department of Medicine, School of Clinical Sciences at Monash Health, Faculty of Medicine, Nursing & Health Sciences, Monash University, VIC, Australia.
  • Trotman J; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
  • Brasacchio D; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
  • Co M; Eastern Health, Melbourne, VIC, Australia.
  • Li J; Olivia Newton John Cancer Research Institute at Austin Health, Melbourne, VIC, Australia.
  • Ramakrishnan V; St George Hospital, Sydney, NSW, Australia.
  • Dunne K; St George & Sutherland Clinical School, University of NSW, Sydney, Australia.
  • Opat SS; Department of Hematology, Concord Repatriation General Hospital, Sydney, NSW, Australia.
  • Gregory GP; Concord Clinical School, University of Sydney, Sydney, NSW, Australia.
Blood Adv ; 7(14): 3531-3539, 2023 07 25.
Article en En | MEDLINE | ID: mdl-36947202

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfoma de Células B de la Zona Marginal / Factor 88 de Diferenciación Mieloide Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Blood Adv Año: 2023 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfoma de Células B de la Zona Marginal / Factor 88 de Diferenciación Mieloide Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Blood Adv Año: 2023 Tipo del documento: Article País de afiliación: Australia